The first malaria treatment suitable for babies and very young children has been approved for use.
The treatment developer, Novartis, said it is expected to be rolled out in African countries within weeks.
It has been approved by Swiss authorities for use in babies weighing between 2 kilograms (4 pounds, 6 ounces) and 5 kilograms (11 pounds).
Until now, there has been no approved malaria treatment for infants weighing less than 4.5 kilograms, instead it was treated with drugs designed for older children that presents risks.
According to World Health Organization, there were 263 million cases of malaria and 597,000 deaths in 2023, with almost all of them in Africa.
Children under the age of 5 accounted for about three in four malaria deaths in the region.
